Resmed Inc. · NYSE:RMD
Resmed — Merger or Acquisition (June 2022)
10 slides from Resmed's merger presentation, Jun 14, 2022
Slide 1: Acquisition of MEDIFOX DAN
Acquisition of MEDIFOX DAN June 14, 2022 Exhibit 99.2
Slide 2: Forward-looking statements
Forward-looking statements Historical financial and operating data in this presentation reflect the consolidated results of ResMed Inc., its subsidiaries, and its legal entities, for the periods indicated. This presentation includes financial information prepared in accordance with accounting princi
Slide 3: Creation of a global leader in out-of-hospital software
Creation of a global leader in out-of-hospital software Leading provider of mission critical software in out-of-hospital markets across the U.S. Leading provider of end-to-end software solutions for home health providers, nursing homes, and outpatient therapy practices in Germany
Slide 4: Creation of a global leader in out-of-hospital software (cont'd)
Creation of a global leader in out-of-hospital software (cont’d) 2 Accelerates ResMed’s efforts to bring software technology along with digital innovation to out-of-hospital care settings 1 3 4 Strategic expansion of software portfolio into Europe Acquisition of market leader in Germany Attractive f
Slide 5: MEDIFOX DAN snapshot
MEDIFOX DAN snapshot By the numbers At a glance Based on a EUR/USD rate of 1.053. Pro forma adjusted for acquisitions. $83M PF Revenue(1,2) (CY 2021) $35M PF Adj. EBITDA(1,2) (CY 2021) 14% Organic Revenue CAGR(2) (CY19 – CY21) 8K+ Customers 600 Employees Leading software provider within growing Germ
Slide 6: Comprehensive software solution across care provider workflows
Comprehensive software solution across care provider workflows Outpatient Therapy Nursing Home Home Health Software: Core modules & extensions Billing & administration Care planning & documentation (AI-based) Staff rostering & task management (AI-based) Route planning Stakeholder portal E-Learning O
Slide 7: Care providers in Germany are increasingly turning to technology for efficiencies
Care providers in Germany are increasingly turning to technology for efficiencies Source: Industry research, ResMed analysis. MEDIFOX DAN complements ResMed’s existing presence in Germany Together with MEDIFOX DAN, ResMed is positioned to support and enhance care in Germany Aging and more acute popu
Slide 8: MEDIFOX DAN accelerates the out-of-hospital software strategy and solution suite
MEDIFOX DAN accelerates the out-of-hospital software strategy and solution suite Comprehensive software platform for out-of-hospital care Mission critical software and data solutions Billing and administration Clinical care plan Documentation Personnel planning Software Solutions and Data Home Medic
Slide 9: Transaction summary
Transaction summary Transaction details Financial highlights Enterprise value of approximately $1.0B(1) (€950M) All-cash consideration, to be financed with existing cash and debt capacity CY 2021 PF Revenue of $83M(1,2) and PF Adj. EBITDA of $35M(1,2) Strong double-digit organic growth profile CY 20
Slide 10: Q&A
Q&A ResMed